These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 25308183

  • 1. Is infection with hypermutable Pseudomonas aeruginosa clinically significant?
    Auerbach A, Kerem E, Assous MV, Picard E, Bar-Meir M.
    J Cyst Fibros; 2015 May; 14(3):347-52. PubMed ID: 25308183
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
    Ciofu O, Riis B, Pressler T, Poulsen HE, Høiby N.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
    Alcalá-Franco B, Montanari S, Cigana C, Bertoni G, Oliver A, Bragonzi A.
    J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
    [Abstract] [Full Text] [Related]

  • 4. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
    Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, Govan JRW.
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
    [Abstract] [Full Text] [Related]

  • 5. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA.
    Lancet; 1996 Sep 07; 348(9028):639-42. PubMed ID: 8782753
    [Abstract] [Full Text] [Related]

  • 6. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M, Hubert D, Burgel PR, Génin E, Honoré I, Martinez B, Gaitch N, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T.
    Clin Respir J; 2016 Nov 07; 10(6):777-783. PubMed ID: 25763772
    [Abstract] [Full Text] [Related]

  • 7. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Rees VE, Deveson Lucas DS, López-Causapé C, Huang Y, Kotsimbos T, Bulitta JB, Rees MC, Barugahare A, Peleg AY, Nation RL, Oliver A, Boyce JD, Landersdorfer CB.
    Antimicrob Agents Chemother; 2019 Apr 07; 63(4):. PubMed ID: 30745381
    [Abstract] [Full Text] [Related]

  • 8. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
    Hogardt M, Hoboth C, Schmoldt S, Henke C, Bader L, Heesemann J.
    J Infect Dis; 2007 Jan 01; 195(1):70-80. PubMed ID: 17152010
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov 01; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.
    Taylor RF, Hodson ME, Pitt TL.
    Thorax; 1993 Oct 01; 48(10):1002-5. PubMed ID: 8256228
    [Abstract] [Full Text] [Related]

  • 15. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
    Oliver A, Cantón R, Campo P, Baquero F, Blázquez J.
    Science; 2000 May 19; 288(5469):1251-4. PubMed ID: 10818002
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
    Rosales-Reyes R, Rodríguez-Alvarado M, Lezana-Fernández JL, Sánchez-Lozano JY, Gayosso-Vázquez C, Jarillo-Quijada MD, Toledano-Tableros JE, Arredondo-Mercado MJ, Alcántar-Curiel MD, Lincopan N, Vidal JE, Lascurain R, Valvano MA, Santos-Preciado JI.
    Pediatr Infect Dis J; 2020 Oct 19; 39(10):899-906. PubMed ID: 32453200
    [Abstract] [Full Text] [Related]

  • 17. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F.
    Pediatr Pulmonol; 2009 Aug 19; 44(8):820-5. PubMed ID: 19598278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J, Hogardt M.
    J Infect Dis; 2009 Jul 01; 200(1):118-30. PubMed ID: 19459782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.